Saxagliptin anhydrous

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8I7IO46IVQ. European Medicines Agency schedules Saxagliptin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25220. Saxagliptin generally arises in the molecular formula C18H25N3O2. The term SAXAGLIPTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19, no. 3, 2005, list 54.) Most nations, for tariff and trade purposes, schedule saxagliptin anhydrous under HS 29339990. As of Q4 2014, SAXAGLIPTIN ANHYDROUS remains US FDA's Preferred Term for this commodity. Saxagliptin anhydrous bears US NLM identifiers UMLS ID C2699273 and NCI Concept Code C75984. SMILES: C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H]([C@]34C[C@@H]5CC(C3)C[C@@](C5)(C4)O)N.